Meghan is the VP of Programs, Portfolio and Operations for Sionna. She brings over 15 years of experience in strategic operations and planning, program leadership, medical affairs and scientific communications. Most recently Meghan was Vice President at Sage Therapeutics, where she held multiple leadership positions including Head of Program, Portfolio and Alliance Management and Head of Medical Communications & Operations. Meghan has previously held positions within small and large companies including Infinity Pharmaceuticals and Takeda Pharmaceuticals.
She began her career within academia, managing research teams at Dana Farber Cancer Institute and University of California San Francisco. Meghan received her B.A. in chemistry from Smith College.